|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||
|
||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s1107575E-5E5B-11EF-809C-381185CE164B&I=39IZM&T=&OP=Display&O=html&O1=15637752&O2=954927539070&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DExtracorporeal%2520partial%2520nephrectomy%2520and%2520auto-transplantation%2520after%2520presurgical%2520targeted%2520therapy%2520with%2520tyrosine%2520kinase%2520inhibitors%2520for%2520renal%2520cell%2520cancer%26rft.au%3DHosoya%252C%2520Noriyuki%26rft.au%3DKanno%252C%2520Hidenori%26rft.au%3DNishida%252C%2520Hayato%26rft.au%3DSakurai%252C%2520Toshihiko%26rft.date%3D2013-08-01%26rft.externalDocID%3D23995527%26rft.genre%3Darticle%26rft.issn%3D0018-1994%26rft.issue%3D8%26rft.jtitle%3DHinyokika%2520kiyo.%2520Acta%2520urologica%2520Japonica%26rft.spage%3D507%26rft.volume%3D59%26rft_id%3Dinfo%253Apmid%252F23995527%26rft_id%3Dinfo%253Apmid%252F23995527%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-MESSAGE_NO_FULLTXT_LCL-getMessageNoFullTxt-object,2-COBIB_SI_LCL-getHolding-object,3-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,4-REFWORKS_EXPORT_TOOL-getReference-object,5-NCBI_PUBMED_FREE-getCitedRecord-object,6-GOOGLE_SCHOLAR_FREE-getWebSearch-object,7-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.042486&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15637752-s1107575E-5E5B-11EF-809C-381185CE164B" timestamp="2024-08-19T20:44:29Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:954927539070</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>[Extracorporeal partial nephrectomy and auto-transplantation after presurgical targeted therapy with tyrosine kinase inhibitors for renal cell cancer].</jnl:atitle>
<jnl:jtitle>泌尿器科紀要</jnl:jtitle>
<jnl:date>2013-08-00</jnl:date>
<jnl:spage>507</jnl:spage>
<jnl:epage>511</jnl:epage>
<jnl:coden>HIKYAJ</jnl:coden>
<jnl:issn>0018-1994</jnl:issn>
<jnl:volume>59</jnl:volume>
<jnl:issue>8</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>0018-1994</jnl:eissn>
<jnl:language>jpn</jnl:language>
<jnl:coden>HIKYAJ</jnl:coden>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:4d206d65b6c2e964f42d0df56d9a0e81760414ed</ctx:identifier>
<ctx:identifier>urn:UUID:s1107575E-5E5B-11EF-809C-381185CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)